Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy

Clinical trial NCT06862596 · RECRUITING

Trial details

NCT number: NCT06862596
Sponsor: Masahisa Katsuno
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Spinal and Bulbar Muscular Atrophy

Start date: 2025-02-28
Primary completion: 2027-12-31
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.